Finerenone is the first therapy targeting the mineralocorticoid receptor pathway to demonstrate cardiovascular benefits in heart failure patients
The company shall process the change of name application with BSE Ltd. in due course
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Presbyopia, the age-related loss of near vision, could soon be treated successfully
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
The upcoming facility marks a strategic milestone in SOUKYA’s mission to make evidence-based holistic healthcare
The anatomage table is one of the most advanced 3D real-tissue–based anatomy visualization systems in the world
Several technologies for hemoglobinopathies are being transferred to commercial partners
Subscribe To Our Newsletter & Stay Updated
